LncRNA ANRIL Regulates Ovarian Cancer Progression and Tumor Stem Cell-Like Characteristics via miR-324-5p/Ran Axis [Retraction]

Wang K, Hu YB, Zhao Y, Ye C. Onco Targets Ther.  2021;14:565— 576. The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. It was bought to the journal’s attention that several figures within the article appea...

Full description

Bibliographic Details
Main Authors: Wang K, Hu YB, Zhao Y, Ye C
Format: Article
Language:English
Published: Dove Medical Press 2021-03-01
Series:OncoTargets and Therapy
Subjects:
Online Access:https://www.dovepress.com/retraction-lncrna-anril-regulates-ovarian-cancer-progression-and-tumo-peer-reviewed-article-OTT
id doaj-460f3ee5efae4312be19af0481ebf637
record_format Article
spelling doaj-460f3ee5efae4312be19af0481ebf6372021-03-30T18:31:21ZengDove Medical PressOncoTargets and Therapy1178-69302021-03-01Volume 142235223663531LncRNA ANRIL Regulates Ovarian Cancer Progression and Tumor Stem Cell-Like Characteristics via miR-324-5p/Ran Axis [Retraction]Wang KHu YBZhao YYe CWang K, Hu YB, Zhao Y, Ye C. Onco Targets Ther.  2021;14:565— 576. The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. It was bought to the journal’s attention that several figures within the article appeared to have duplicated images,specifically: ● Figure 4E panel 0 h si-ANRIL R2 appears to be duplicated with Figure 4E panel 0 h miRNC.● Figure 5A panel si-NC appears to share duplicated regions with Figure 5A panel miR-NC.● Figure 5C row ALDH CD133, the far left and centre right flow cytometry panels appear to show duplicated regions.● Figure 5C row ALDH CD133, the centre left and far right flow cytometry panels appear to show duplicated regions.● Figure 5C row CD117 CD44, the far left and centre right flow cytometry panels appear to show duplicated regions.● Figure 5C row CD117 CD44, the centre left and far right flow cytometry panels appear to show duplicated regions.● Figure 5C row Notch1 CD24, the far left and centre right flow cytometry panels appear to show duplicated regions.● Figure 5C row Notch1 CD24, the centre left and far right flow cytometry panels appear to show duplicated regions.● Figure 6D panel si-NC appears to share duplicated regions with Figure 6D panel si-ANRIL R2+pcDNARan.● Figure 6D panel si-ANRIL R2 appears to share duplicated regions with Figure 6D panel si-ANRIL R2 +pcDNA. The authors were unable to provide a satisfactory explanation for the alleged duplication and were unable to provide the original images used in the figures. The editor determined the findings of the article were no longer valid and requested for the article to be rejected. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paperhttps://www.dovepress.com/retraction-lncrna-anril-regulates-ovarian-cancer-progression-and-tumo-peer-reviewed-article-OTTanrilovarian cancertumorigenicitymigrationdrug resistancecancer stem cell
collection DOAJ
language English
format Article
sources DOAJ
author Wang K
Hu YB
Zhao Y
Ye C
spellingShingle Wang K
Hu YB
Zhao Y
Ye C
LncRNA ANRIL Regulates Ovarian Cancer Progression and Tumor Stem Cell-Like Characteristics via miR-324-5p/Ran Axis [Retraction]
OncoTargets and Therapy
anril
ovarian cancer
tumorigenicity
migration
drug resistance
cancer stem cell
author_facet Wang K
Hu YB
Zhao Y
Ye C
author_sort Wang K
title LncRNA ANRIL Regulates Ovarian Cancer Progression and Tumor Stem Cell-Like Characteristics via miR-324-5p/Ran Axis [Retraction]
title_short LncRNA ANRIL Regulates Ovarian Cancer Progression and Tumor Stem Cell-Like Characteristics via miR-324-5p/Ran Axis [Retraction]
title_full LncRNA ANRIL Regulates Ovarian Cancer Progression and Tumor Stem Cell-Like Characteristics via miR-324-5p/Ran Axis [Retraction]
title_fullStr LncRNA ANRIL Regulates Ovarian Cancer Progression and Tumor Stem Cell-Like Characteristics via miR-324-5p/Ran Axis [Retraction]
title_full_unstemmed LncRNA ANRIL Regulates Ovarian Cancer Progression and Tumor Stem Cell-Like Characteristics via miR-324-5p/Ran Axis [Retraction]
title_sort lncrna anril regulates ovarian cancer progression and tumor stem cell-like characteristics via mir-324-5p/ran axis [retraction]
publisher Dove Medical Press
series OncoTargets and Therapy
issn 1178-6930
publishDate 2021-03-01
description Wang K, Hu YB, Zhao Y, Ye C. Onco Targets Ther.  2021;14:565— 576. The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. It was bought to the journal’s attention that several figures within the article appeared to have duplicated images,specifically: ● Figure 4E panel 0 h si-ANRIL R2 appears to be duplicated with Figure 4E panel 0 h miRNC.● Figure 5A panel si-NC appears to share duplicated regions with Figure 5A panel miR-NC.● Figure 5C row ALDH CD133, the far left and centre right flow cytometry panels appear to show duplicated regions.● Figure 5C row ALDH CD133, the centre left and far right flow cytometry panels appear to show duplicated regions.● Figure 5C row CD117 CD44, the far left and centre right flow cytometry panels appear to show duplicated regions.● Figure 5C row CD117 CD44, the centre left and far right flow cytometry panels appear to show duplicated regions.● Figure 5C row Notch1 CD24, the far left and centre right flow cytometry panels appear to show duplicated regions.● Figure 5C row Notch1 CD24, the centre left and far right flow cytometry panels appear to show duplicated regions.● Figure 6D panel si-NC appears to share duplicated regions with Figure 6D panel si-ANRIL R2+pcDNARan.● Figure 6D panel si-ANRIL R2 appears to share duplicated regions with Figure 6D panel si-ANRIL R2 +pcDNA. The authors were unable to provide a satisfactory explanation for the alleged duplication and were unable to provide the original images used in the figures. The editor determined the findings of the article were no longer valid and requested for the article to be rejected. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper
topic anril
ovarian cancer
tumorigenicity
migration
drug resistance
cancer stem cell
url https://www.dovepress.com/retraction-lncrna-anril-regulates-ovarian-cancer-progression-and-tumo-peer-reviewed-article-OTT
work_keys_str_mv AT wangk lncrnaanrilregulatesovariancancerprogressionandtumorstemcelllikecharacteristicsviamir3245pranaxisretraction
AT huyb lncrnaanrilregulatesovariancancerprogressionandtumorstemcelllikecharacteristicsviamir3245pranaxisretraction
AT zhaoy lncrnaanrilregulatesovariancancerprogressionandtumorstemcelllikecharacteristicsviamir3245pranaxisretraction
AT yec lncrnaanrilregulatesovariancancerprogressionandtumorstemcelllikecharacteristicsviamir3245pranaxisretraction
_version_ 1724179048292155392